Regeneron’s Gene Therapy Approved as First Treatment for Genetic Hearing Loss
The U.S. Food and Drug Administration has approved the first-ever gene therapy for inherited deafness, a one-time treatment developed by Regeneron Pharmaceuticals targeting mutations in the OTOF gene that cause ... Read More